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doi:10.10Abstract: Although it has been accepted that depression and pain are common comorbidities, their
interaction is not fully understood. The present study was aimed to investigate the effects of depres-
sion on both evoked pain behavior (thermal-induced nociception and hyperalgesia) and spontaneous
pain behavior (formalin pain) in rats. An unpredictable chronic mild stress (UCMS) paradigm was em-
ployed to develop a classical depression. The emotional behaviors were assessed by sucrose prefer-
ence test, open field test, and elevated plus-maze test. The results showed that the depressed rats
always exhibited stronger tolerance to noxious thermal stimulation under both normal and complete
Freund’s adjuvant (CFA)-induced chronic pain conditions, when compared to nondepressed animals.
Interestingly, the spontaneous nociceptive behaviors induced by formalin injection were significantly
enhanced in rats exposed to UCMS in comparison to those without UCMS. Systemic administration of
antidepressant fluoxetine significantly restored the nociceptive behaviors to normal level in de-
pressed animals. An additional finding was that the inflammatory rats tended to display depres-
sive-like behaviors without being exposed to UCMS. These results demonstrated that depression
can have different effects on stimulus-evoked pain and spontaneous pain, with alleviation in the for-
mer while aggravation in the latter.
Perspective: The present study provides evidence that depression can have divergent effects on
stimulus-evoked and spontaneous pain by confirming that rats exposed to chronic mild stress tend
to exhibit decreased pain sensitivity to experimental stimuli but increased intensity of ongoing
pain. This may contribute to further understanding of the perplexing relationship between clinical
depression and chronic pain.
ª 2010 by the American Pain Society
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tween pain and depression has attracted increasing
attention in all areas of research due to its multiple
applications. In clinical practice, depression is often asso-
ciated with an increased incidence of clinical pain com-
plaints and, thus, the comorbidity of pain and
depression has been suggested to be a common phe-
nomenon.21,24 Previous studies indicate that pain and
depression share common neuroanatomical pathwaysMay 14, 2009; Revised July 1, 2009; Accepted July 13, 2009.
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16/j.jpain.2009.07.002and neurobiological substrates, which might explain
the increased vulnerability to pain in depressive patients
and vice versa. A population-based study found that
43.4% of patients with depression had at least 1 painful
physical symptom, which was 4 times the rate of patients
who did not suffer from depression. The results also
showed that the prevalence of depression in patients
with pain symptoms was higher than those without
pain symptoms.30 To describe the relationship between
pain and depression, some experiments on patients
with depressive disorders have been performed. Most
studies regarding depressed patients found increased
pain thresholds,5,14,22,23 while a few reports described
a decrease in the experimentally evoked pain.27,29 Thus,
the correlation between depression and pain is still
a matter of debate and has not been fully understood.
Animal studies showed similar results in that the noci-
ceptive behaviors were either reduced 33 or enhanced3,47
in subjects exposed to chronic environmental stress,
a condition that has been demonstrated to cause219
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depression on nociceptive behaviors may be due to the
use of various animal models and varied experimental
procedures. Lautenbacher and Krieg22 proposed an
interesting hypothesis of a global impairment of the
sensory system in depression which involves: 1) hypoal-
gesia to phasic experimental pain due to diminished
spinal and brainstem transmission; and 2) hyperalgesia
to endogenous painful sensations (eg, clinical com-
plaints of headache, stomach pain, etc.) because of the
insufficient activation of inhibitory systems.
The unpredictable chronic mild stress (UCMS) animal
model is one of the classical depression models intro-
duced by Willner et al.44 The paradigm consists of several
mild stressors which are analogous to those associated
with humans. In this paradigm, animals are subjected to
a variety of unpredictable mild stressors every day. After
several weeks, the animals show a decrease in consump-
tion of a palatable sweet solution, known as anhedonia,
which is the core character of depression.45 In our study,
the UCMS procedure was utilized as an animal model of
depression, based on well-established methods found in
the literature with modifications.44 We aimed to explore
the effect of depression on both evoked pain behavior
(thermal-induced nociception and hyperalgesia) and
spontaneous pain behavior (formalin pain, which is closer
to clinical persistent pain). We hypothesized that: 1) the
thermal nociception and hyperalgesia will be attenuated
whereas the formalin pain exacerbated after weeks of
UCMS exposure; and 2) the nociceptive behaviors of
UCMS-treated rats will be restored to normal levels in
response to an antidepressant treatment.Methods
Animals
Male Wistar rats (purchased from the Academy of Mil-
itary Medical Science, Beijing, China) weighing 220 to
250 g at the beginning of experiment were used. All
rats were housed individually with food and water freely
available and maintained under a standard 12/12 hour
light/dark cycle (lights on at 0700), with ambient temper-
ature set at 22 6 2C. Animals were softly handled 3 to 5
minutes per day by the experimenter before the onset of
the experiment. All experimental procedures were ap-
proved by the International Review Board of the Insti-
tute of Psychology, Chinese Academy of Sciences.
Experimental Design
Rats were randomly assigned to 2 groups; control
group and UCMS group. The control and UCMS-exposed
animals were kept in separate rooms in order to indepen-
dently manipulate the environments. Testing was per-
formed during the light cycle. Rats were allowed to
acclimate for at least 1 week. Then rats in the UCMS
group were subjected to 6 weeks of mild, unpredictable
stressors. Body weights were measured weekly during
the UCMS procedure.
Three studies were performed. The first study
examined the effect of chronic stress exposure on thepain-related behaviors (including thermal thresholds of
acute and chronic pain, and formalin-induced licking be-
havior). The experimental protocol was shown in Table 1.
The depression-related behaviors were assessed before
(baseline) and after the UCMS procedure by the su-
crose-consumption, the open-field, and the elevated
plus-maze (EPM) tests. Both control and UCMS groups
were further divided into 3 subgroups, which respec-
tively received thermal acute pain, complete Freund’s ad-
juvant (CFA)-induced hyperalgesia, and formalin tests.
The acute thermal-pain test and formalin test were per-
formed both before (baseline) and/or after UCMS proce-
dure (the 6th week). CFA was injected during the second
weekend. The thermal hyperalgesia was evaluated once
every week until the end of the experiment. The control
group received the same treatment except that it was
not exposed to UCMS. The hypothalamic-pituitary-adre-
nal (HPA) activity (the adrenal weight and the blood level
of plasma corticosterone) was examined after the com-
pletion of all behavioral tests.
The second study investigated whether the stress-in-
duced changes in pain behavior could be reversed by an-
tidepressant fluoxetine. Rats were injected ip daily with
fluoxetine from the third week until the end of the
UCMS procedure. The control group was treated with sa-
line. The reason that the antidepressant treatment be-
gan in the middle but not at the beginning of the
protocol was that we needed to make sure that the
rats exhibited depressive behaviors and the model was
successful prior to antidepressant treatment.37 The pro-
tocols for acute thermal pain and formalin pain were
the same as in the first study. In the CFA pain test, rats
were injected with CFA at the end of the 6-week UCMS
procedure. The thermal hyperalgesia was measured 24
hours following CFA injection.
The third study was done to observe whether rats with
chronic pain tend to develop depressive-like behaviors.
Rats were divided into a control group and an experi-
mental group, receiving intraplantar injection of saline
and CFA, respectively. The behavioral reactivity to vari-
ous paradigms (sucrose preference, locomotor activity
in the open field, and EPM) was measured, and HPA ac-
tivity examined during a 6-week period of observation.UCMS Procedure and Behavioral Tests
Table 2 describes the schedule of stressor administra-
tion. Stressors were unpredictable in their nature, dura-
tion, and frequency. Stress procedures included, in
a pseudorandom order: 22- and 40-hour periods of water
deprivation; 20- and 22-hour periods of food depriva-
tion; one 1-hour period of empty water bottle (exposed
to empty water bottle immediately after one 40-hour pe-
riod of water deprivation); one 3-hour period of re-
stricted access to food (2 small pieces of pellet in each
cage) following one 20-hour period of food deprivation;
8- and 16-hour periods of cage tilt (45); 7- and 8-hour pe-
riods of strobe light; two 16-hour periods of soiled bed-
ding; one 16-hour period of group housing (8 rats in
a cage); two 16-hour periods overnight illumination;
2- and 5-hour periods of intermittent white noise
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Abbreviations: UCMS, unpredictable chronic mild stress; EPM, elevated plus-
maze test; OF, open field test; PT, pain threshold test; Ft, formalin test.
Table 2. Procedure of Unpredictable Chronic
Mild Stress
TIME TYPES OF STRESS
Monday
09:00 Clean cages, dry cages, commence strobe light
16:00 End strobe light and commence hot room (40C) for
30 minutes
17:00 Commence water deprivation and paired housing
Tuesday
09:00 End paired housing and commence cage tilting
17:00 End cage tilting and expose to novel odor. Switch
lights to on overnight
Wednesday
09:00 Remove novel odor and exposed to empty water
bottle for 1 hour
10:00 Restore water
12:00 Commence cold room (10C) for 30 minutes
17:00 Soil cage
Tuesday
07:00 Reverse the light/dark cycle for 24 hours
09:00 Clean cage, commence food deprivation and exposed
to hot room (40C) for 30 minutes
17:00 Commence crowding (8 rats per cage)
Friday
09:00 End crowding and commence strobe light
17:00 End strobe light, restricted access to food (2 small
pieces of pellet in each cage) for 3 hours
20:00 Restore food and switch lights to on overnight
Saturday
09:00 Commence cold room (10C) for 30 minutes
16:00 Remove water and food
17:00 Commence cage tilting and exposure to novel odor
Sunday
09:00 End cage tilting and remove novel odor
14:00 Sucrose preference test for 1 hour
15:00 Restore water and food
17:00 Soil cage
Shi, Wang, and Luo 221(75 dB); two 16-hour periods of novel odor; two 30-minute
periods of exposure to a hot room (40C); and two 30-min-
ute periods of exposure to a cold room (10C) (Table 2).
Sucrose preference tests were performed before (base-
line) and weekly after UCMS. At the start of the experi-
ment, the animals were first trained to drink a 1%
sucrose solution, by exposing them to sucrose instead
of water for 48 hours. Then, the rats received a series
of sucrose preference tests, preceded by 22 hours food
and water deprivation. Each animal was presented simul-
taneously with 2 bottles, one containing sucrose solution
(1%) and the other containing water. The percent prefer-
ence for sucrose consumption was calculated according
to the following formula: % sucrose preference = (su-
crose solution consumption/[sucrose solution consump-
tion 1 water consumption])  100.
The open field test was applied to analyze the free lo-
comotion and exploration of rats. The open field appara-
tus consisted of a circular area (180 cm in diameter and
50-cm wall height) in a quiet room with dim illumination
(40 W). An object—a blue cylinder (7 cm high and 15 cm
in diameter) —was put into the center of the open field.
The animals were placed individually into the center fac-
ing the same position of the wall in all of the tests. Each
animal was recorded for 5 minutes to monitor the dis-
tance it traveled and the times it explored the object. A
video recording camera was mounted to the ceiling
above the observation chamber to record and input
the activity in a computer. Rat behavior was recorded
and analyzed using a computer-based system Etho Vision
(Noldus Information Technology, Wageningen, The
Netherlands). In the interval between each 2 animal
tests, the apparatus was cleaned with ethanol and water
to remove olfactory cues.
The EPM test was carried out to measure the emotional
reactivity of rats. The instrument consisted of 2 open
arms (50.8  10.2  1.3 cm) and 2 closed arms (50.8 
10.2  4.6 cm), arranged perpendicularly, and was ele-
vated to a height of 72.4 cm above the floor. The arms
were connected by a central square (10.2  10.2 cm).
The apparatus was in a quiet room exposed to dim illumi-
nation. Rats were placed individually in the center of the
maze facing an open arm, and observed for 5 minutes.
The time spent in open arms was recorded and analyzedby a computer-based system (MED-VPM-RS; Med Associ-
ate Inc., St. Albans, VT).
Radiant heat was employed to induce acute pain and
to access the hyperalgesia related to chronic pain. Ani-
mals were placed into a Plexiglas chamber on a glass
floor and allowed to acclimate for at least 30 minutes.
Then, a radiant heat stimulus was applied to the plantar
surface of the hind paw. The paw withdraw latency
(PWL) induced by the radiant heat was used as a measure
of pain thresholds and thermal hyperalgesia. Five trials
were conducted on each hind paw at an interval of 5
minutes. Because of considerable variability in the first
latency measurement, the average of the last 4 PWL mea-
surements was used to determine the PWL.
Chronic inflammatory pain was induced by a subcuta-
neous injection into the unilateral hind paw of 100 mL of
CFA (Sigma, St. Louis, MO). The thermal thresholds were
measured before UCMS procedure as the baseline and at
7, 14, 21, and 28 days after CFA injection.
In the formalin test, 50 mL of 5% formalin was injected
into the rat hind paw. The rats were immediately re-
turned to the testing chamber and the behaviors were
recorded by a computer-based video recording system
222 Depression Regulates Evoked and Spontaneous Painfor 60 minutes. The time spent licking the injected paw
was calculated in 5-minute epochs.
Blood Corticosterone Level and Adrenal
Weight
At the end of the experiments, the rats were decapi-
tated. Blood samples from trunk vessel were immediately
collected for corticosterone determination. Meanwhile,
the adrenals were quickly removed and weighed. The ad-
renal weight is expressed relative to body weight (in mg/g
body weight). The blood samples were centrifuged at
3,000 rpm for 15 minutes to obtain cell-free plasma and
then frozen at –80 to store. The levels of plasma cortico-
sterone were measured by enzyme linked immunosor-
bent assay (ELISA) using a commercial kit (Rapidbio Lab,
Calabasas, California).
Antidepressant Treatment
The selective serotonin reuptake inhibitor fluoxetine
was purchased from Sigma-Aldrich (St. Louis, Missouri)
and dissolved in saline (.9% NaCl) immediately before
application. Separate subgroups of stressed and non-
stressed animals were treated chronically with daily ip in-
jection of either fluoxetine (10 mg/kg/day) or normal
saline (NS) (at 1700) from day 22 through day 42.
Statistical Analysis
GraphPad prism 4.0 (GraphPad Softward, Inc., La Jolla,
CA) and Statistica 5.1 (Statsoft, Inc., Tulsa, OK) were used
for statistical analyses and graph generation. Data af-
fected by 2 or 3 factors were analyzed with multifactor
analysis of variance (ANOVA). Duncan’s test was used
for post hoc test. Student’s t-test was employed when 2
groups were compared. Relationships between nocicep-
tive behaviors and sucrose preference were examined
with Pearson correlation coefficients. The data was pre-
sented as means 6 SEM. The statistical significance was
set at P < .05.Results
UCMS Model
Body weights were measured weekly during the UCMS
procedure. Initially the mean body weight of rats did not
differ between UCMS and control groups (226.8 6 1.7 g
vs 229.0 6 2.3 g, t(93) = .8345, P = .4061). Over the 6-week
experiment, a consistent reduction in the weight gain
was observed in the UCMS-exposed rats, and 2-way AN-
OVA revealed significant difference between the 2
groups (F(5, 558) = 101.6, P < .001) (Fig 1A).
The results of sucrose preference test are shown in Fig
1B. Significant reduction was found in sucrose consump-
tion after 2 weeks of UCMS, which was maintained
throughout the observation period (6 weeks) (F(5,
546) = 5.699, P < .001). This indicates that the depression
animal model has been successfully established.
The locomotor (travel distance) and exploratory behav-
ior in the open field were also significantly altered follow-
ing UCMS exposure. As shown in Fig 1C, UCMS-exposedrats showed significantly higher level of locomotor activ-
ity (3367 6 278 vs 2757 6 192 cm, P < .01) and lower level
of exploratory activity (5.68 6 .74 vs 8 6 .74, P < .05) com-
pared with the control group. This suggests that rats
exposed to UCMS exhibited depressive behaviors.
Anxiety behaviors of rats were measured by the time
spent in the open arms in EPM. As shown in Fig 1D, the
baseline level did not show significant difference be-
tween control and UCMS groups. By contrast, UCMS-ex-
posed rats preferred to spend more time in the open
arms compared to the control rats (83.57 6 8.85 vs
31.08 6 3.51 seconds, P < .05). The increased EPM open-
arm time during UCMS exposure indicates that the
chronic mild stress has an anxiolytic effect but not an
anxiogenic effect.
In addition, UCMS-treated rats displayed remarkable
adrenal hypertrophy (.189 6 .010 vs .136 6 .005 g/kg,
t(50) = 1.388, P < .001) compared with control rats (Fig
1E), suggesting an increased activity of HPA axis. Unlike
the results obtained in adrenal weight examination, no
significant difference was found in the plasma levels of
corticosterone between UCMS and control groups
(t(33) = 1.983, P = .056). This may be due to an adaptive
response of corticosterone release during the 6-week
period of UCMS procedure.The Effect of Depression on Pain
Behaviors
The Effect of Depression on Evoked Pain Be-
haviors
Acute thermal pain tests were performed before (base-
line) and 6 weeks after UCMS. As can be seen in Fig 2A,
UCMS exposure produced significantly changed PWLs
compared to the control group (7.71 6 .19 vs 6.37 6
.11 seconds, P < .01), suggesting that depressed subjects
had higher pain thresholds in response to experimental
painful stimuli.
For CFA-injected rats, PWL was accessed weekly after
inoculation. The injected paw looked red and tumid im-
mediately after the injection. The rats showed limping
and paw elevation, and kept licking and shaking the in-
flamed hindpaw. As shown in Fig 2B, UCMS-treated rats
exhibited significantly longer PWL to noxious thermal
stimuli than control animals in ANOVA (Group effect:
F(1, 120) = 26.75; P < .001), consistent with the result of
acute thermal pain.
The Effect of Depression on Spontaneous Pain
Behavior
Subcutaneous injection of formalin into the hind paw
produced a typical biphasic pattern of licking behavior,
as shown in Fig 2C1. Compared with the control rats,
the licking behaviors in the UCMS rats were significantly
enhanced throughout the entire hour of observation
(Group effect: F(1, 372) = 77.68). Cumulative licking time
clearly showed the increase in phase I (0 to 5 minutes,
120.2 6 6.7 seconds vs 94.1 6 5.3 seconds, t(31) = 3.1000,
P < .01), interphase (5 to 15 minutes, 104.2 6 12.7 seconds
vs 46.7 6 5.7 seconds (control), t(31) = 4.212, P < .001), and
Figure 1. The depressive-like behaviors after 6 weeks of unpredictable chronic mild stress (UCMS) procedure. (A) Body weight. Over
the 6-week UCMS exposure, the body weights in the UCMS group were significantly decreased (n = 46–47). (B) Sucrose preference.
Two weeks after UCMS, there was a significant reduction in sucrose consumption in the UCMS-exposed rats (n = 47–48). (C) Locomotor
behaviors. The UCMS-treated rats displayed significantly higher level of activity and lower level of exploratory behavior compared
to the control group (n = 24). (D) elevated plus-maze (EPM) test. The time spent in the open arms significantly prolonged in the
UCMS group in comparison to that in the control group (n = 25–26). (E) Activity of hypothalamic-pituitary-adrenal (HPA). The adrenal
weights in the UCMS group were significantly increased, but the concentration of plasma corticosterone did not change (n = 17–18).
Data are presented as mean 6 SEM. *P < .05; **P < .01; ***P < .001, compared to their respective control group.
Shi, Wang, and Luo 223phase II (15 to 60 minutes, 992.9 6 41.3 seconds vs 531.8 6
27.6 seconds (control), t(31) = 9.3800, P < .001, see Fig 2C2).
These results indicate that spontaneous pain behavior was
exacerbated after UCMS exposure.Correlation Between Behaviors of
Depression and Pain
To investigate the seemingly inconsistent results for
evoked and spontaneous pain, Pearson correlations
were computed between the pain and depressive behav-
iors. Significant negative correlations were found be-
tween sucrose preference and pain thresholds in both
acute pain (r = –.4830, P = .0069, see Fig 3A) and thermalhyperalgesia (r = –0.6918, P < .0001, see Fig 3B). This indi-
cates that the sensation and reaction to environmental
noxious events was weakened in the depressed subjects.
A significant correlation was found between sucrose
preference and licking time in formalin pain with corre-
lation coefficients of r = –.5554, –.5898, and –.6371 for
phase I, interphase, and phase II, respectively (Fig 3C).
The fact that the spontaneous pain was intensified in de-
pressive conditions implies that depression may bring
a heightened awareness of persistent, unavoidable
pain, therefore serving to maintain or exaggerate ongo-
ing pain. These results confirmed that depression is asso-
ciated with decreased sensitivity to experimental pain
and increased clinical pain symptoms.
Figure 2. The effect of depression on the evoked vs spontaneous pain behaviors. (A) Acute thermal evoked pain. The paw with-
drawal latency (PWL) to noxious heat stimuli was significantly increased in the stressed rats (n = 16). (B) Thermal-evoked hyperalgesia
in chronic pain state. During the unpredictable chronic mild stress (UCMS) procedure, CFA was injected into the rat hind paw to induce
chronic inflammatory pain. The PWL was significantly higher in the UCMS-exposed rats than in the nonstressed ones (n = 16). (C1and
C2) Spontaneous pain. Subcutaneous injection of formalin into the rat hind paw was used to produce spontaneous pain. Compared
with the control rats, the licking behaviors in the UCMS rats were significantly enhanced in the early and late phases as well as in the
interphase (n = 16–17). Data are presented as mean 6 SEM. *P < .05; **P < .01; ***P < .001, compared to their respective control group.
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Changes in Pain Behavior
Sucrose Preference Test
As shown in Fig 4, sucrose preference was significantly
decreased 3 weeks after UCMS exposure (Group effect:
F(1, 225) = 44.96, P < .001), consistent with prior findings.
While not affecting sucrose intake in the control rats, flu-
oxetine treatment for 3 consecutive weeks produced ap-
parent beneficial effects on the UCMS rats, demonstrated
by improved sucrose consumption in comparison to those
treated with saline.Evoked and Spontaneous Pain Behaviors
Systemic administration of fluoxetine significantly af-
fects the PWL of rats in both acute pain (F(1, 44) =
37.99, P < .001, see Fig 5A) and thermal hyperalgesia
(F(1, 44) = 96.06, P < .001, see Fig 5B). Post hoc analysis re-
vealed that fluoxetine per se had an antinociceptive ef-
fect (ie, elevated pain thresholds) in normal (control)
rats (12.4 6 .48 vs 10.1 6 .27 seconds, P < .001, Fig 5A;
6.53 6 .28 vs 4.19 6 .07 seconds, P < .001, Fig 5B). Further-
more, UCMS-exposed rats exhibited stronger tolerance
to noxious thermal stimulation (13.84 6 .53 vs 10.1 6
.27 seconds, P < .001, Fig 5A; 6.48 6 .25 vs 4.19 6 .07 sec-
onds, P < .001, Fig 5B) compared with control rats, consis-
tent with the previous finding that depression is
associated with decreased sensitivity on experimental
pain. Most importantly, the thermal nociceptive thresh-olds in UCMS-exposed rats were decreased (13.84 6 .53
vs 10.82 6 .41 seconds, P < .001, Fig 5A; 6.48 6 .25 vs
4.57 6 .21 seconds, P < .001, Fig 5B) and approached nor-
mal level following fluoxetine treatment (10.82 6 .41 vs
10.1 6 .27 seconds, P = .25, Fig 5A; 4.57 6 .21 vs 4.19 6 .07
seconds, P = .10, Fig 5B), reflecting the therapeutic effect
of fluoxetine as an antidepressant.
The formalin-induced spontaneous pain behaviors in
both UCMS and control rats were suppressed by fluoxe-
tine administration (for Fig 5C1, F(1, 28) = 42.8,
P < .001; for Fig. 5C2, F(1, 33) = 11.28, P = .002 for Phase
I, F(1, 32) = 68.13, P < .001 for interphase, and F(1, 33) =
41.57, P < .001 for Phase II), confirming the antinocicep-
tive effect of fluoxetine on normal rats and antidepres-
sion effect on depressive ones.
The Chronic Pain-Induced Depression
The possibility that chronic pain may cause depression
was also examined in this study (Fig 6). It was found that
the rats with chronic inflammatory pain exhibited some
depressive-like behaviors, for example, decreased
sucrose consumption (P = .0561). These results support
the idea that individuals suffering from chronic pain
may be more likely to develop depressive disorders.Discussion
In the present study, we investigated the effect of un-
predictable mild stress on evoked pain (thermal stimulus
induced pain and hyperalgesia) and spontaneous pain
Figure 3. The correlation between nociceptive behaviors and sucrose preference. There is a negative correlation between sucrose
preference and thermal pain thresholds in both the acute (A) and chronic pain (B) states. Also, the intensity of spontaneous pain in-
duced by formalin is negatively correlated with sucrose consumption in the early and late phases as well as in the interphase (C).
Figure 4. The therapeutical effect of fluoxetine on depression.
Rats recieved fluoxetine (10 mg/kg/day, ip) administration for
consecutive 21 days. Fluoxetine treatment significantly reversed
sucrose intake reduction in the unpredictable chronic mild stress
(UCMS)-exposed rats in comparison with those administered
with normal saline Data are presented as mean 6SEM. *P <
.05, ***P < .001, compared to their respective non-UCMS group;
#P < .05, ###P < .001, compared to their respective normal saline
(NS)-treated group. n = 12.
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findings that depressed subjects tend to exhibit
decreased pain sensitivity to experimental stimuli but
increased intensity of ongoing pain. Furthermore,
chronic treatment with selective serotonin reuptake
inhibitor fluoxetine reversed the depression-related be-
havioral changes in UCMS-exposed rats. Finally, rats
with chronic inflammatory pain exhibited some depres-
sive-like behaviors, supporting the idea that chronic
pain may bring about clinical depression.
In contrast to the high frequency of clinical pain com-
plaints, most authors reported that depressive patients
were less sensitive to experimental pain.5,6,15,22,23 For ex-
ample, Bär et al5 investigated 30 patients suffering major
depressive disorders and found hypoalgesic responses to
cutaneous thermal or electrical stimuli. Lautenbacher
et al23 observed that the pressure-pain thresholds of
the forearm were significantly higher in depressed pa-
tients than in healthy subjects. Animal studies also dem-
onstrated that rats subjected to a chronic unpredictable
stress paradigm had increased nociceptive thresholds in
the tail-flick test.33 In our study, we found that the rat
model of depression exhibited less sensitivity to noxious
radiant heat applied on the hindpaw in both acute and
chronic pain states, consistent with previous findings.
This indicates that depression may inhibit evoked pain.
Inconsistent data were also reported concerning the re-
sponse of depressed subjects to experimental pain. The
tolerance to ischemic pain produced by a tourniquet
was found to be reduced in depressed patients.32 Bothmechanical allodynia and depression-like behavior
were exacerbated after peripheral nerve injury in Wis-
tar-Kyoto (WKY) rats.47 The possible explanation for
these controversial findings might be the use of nonuni-
fied protocols for pain-threshold measurements as well
as the application of different kinds of stimuli.
Figure 5. The effect of fluoxetine on the depression-induced changes in pain behavior. In both acute (A) and chronic pain (B) states,
the elevated nociceptive thermal thresholds by unpredictable chronic mild stress (UCMS) exposure were reversed and approached
normal level following systemic administration of fluoxetine, indicating the therapeutic effect of fluoxetine as an antidepressant.
In addition, the PWLs of rats in the control group were increased by fluoxetine treatment, suggesting an antinociceptive effect of
fluoxetine per se. (C1 and C2) In spontaneous pain state, the enhanced licking behaviors by UCMS exposure were reversed by
fluoxetine. Additionally, in control rats, the licking behaviors were suppressed by fluoxetine injection. Data are presented as mean
6 SEM. *P < .05; **P < .01; ***P < .001, compared to their respective control group; #P < .05; ##P < .01; ###P < .001, compared to their
respective normal saline (NS)-treated group. n = 9–10.
226 Depression Regulates Evoked and Spontaneous PainWard et al43 supposed that the stress-evoked release of
endogenous opioids might account for the hypoalgesia
in major depressive disorder. Data obtained by Frew
et al12 supported this notion and offered evidence that
systemical administration with m-opioid receptor antago-
nist naltrexone intensified cold- and shock-induced pain
in depressive patients. Bär et al5,6 revealed that depressed
patients displayed elevated thermal-pain thresholds and
demonstrated activation of similar cortical structures be-
tween depressed patients and healthy subjects during
pain processing, including contralateral primary and sec-
ondary somatosensory cortices, insula, anterior cingulate
cortex, and supplementary motor area. More important,
a relative hyperactivation of the prefrontal cortices was
found during the application of painful stimuli in depres-
sive-disorder patients compared to the healthy controls,7
indicating that the prefrontal area may play an important
role in linking pain and depression.
In our experiment, the relationship between spontane-
ous pain and depression was found to be totally different
from evoked-pain condition. In contrast to the reduced
pain sensitivity, the ongoing pain produced by subcutane-
ous formalin injection was significantly intensified in
UCMS-exposed rats. This suggests that depression can fa-
cilitate the spontaneous pain. Clinical studies have shown
that depression is closely associated with an increased fre-
quency of clinical pain complaints.8,46 It is well established
that low levels of central serotonin (5-HT) and norepi-
nephrine (NE) are related to the state of depression.10,25
Also, it has long been known that serotonergic and norad-
renergic projections are involved in the descendingmodulation of pain in addition to regulating mood, rec-
ognition, and attention. Thereby, it is possible that the
painful physical symptoms in depressed subjects are
caused by the dysfunction of descending 5-HT and NE
pathways.41 An additional explanation for the exaggera-
tion of ongoing pain in depressed subjects may be the
emotional effect. As a negative affect, depression may
enhance the emotional response to intense pain (eg, for-
malin-induced pain) while thresholds remain unchanged.
The selective serotonin reuptake inhibitor (SSRI) fluoxe-
tine is widely used in clinical practice for the treatment of
depression.42 It inhibits the reuptake of 5-HT by presynap-
tic neurons, increases the amount of 5-HT present in the
synapse, and helps normalize the transmission of neuronal
signals. In the current study, fluoxetine produced apparent
therapeutic effects on the depressed rats, demonstrated
by improved sucrose consumption in comparison to the sa-
line treated group. After chronic treatment with fluoxe-
tine, the decreased or increased nociceptive behaviors in
evoked or spontaneous pain conditions in the UCMS-ex-
posed rats were all restored to normal level (ie, control
level), confirming that the altered pain perception was re-
lated to the depressive state. Besides, fluoxetine was also
found effective in relieving pain in rats without depres-
sion, as has been found in previous studies.1,38,40 The anti-
nociceptive effect of fluoxetine was thought to be
mediated by the descending serotoninergic inhibitory
pathways. Possibly, the roleof 5-HTinanalgesia isdistinctly
different from the development of depression.
In clinical study, depression seems to be more common
in patients with chronic pain than in those suffering any
Figure 6. The depressive-like behaviors resulted from chronic inflammatory pain. The rats with chronic inflammatory pain showed
lower sucrose preference (near significant level, [B]). Other behavioral indices, including body weight (A), OF test (C), and hypotha-
lamic-pituitary-adrenal (HPA) activity (D), did not show significant changes during the development of chronic pain. Data are
presented as mean 6 SEM. **P < .01, compared to their respective normal saline (NS)-treated group. n = 16.
Shi, Wang, and Luo 227other chronic illness.2 A review of European literature re-
ported that the percentage ofpatientswithdepressivedis-
order ranged from 23.1% (with pain) and 8.8% (without
pain) to 41% and 14.5%, respectively.13 Although there
is much clinical evidence that people with chronic pain
are much more likely to have a depressive disorder, data
from animal studies are very scarce. In the present study,
we found that rats injected with CFA displayed a decrease
(nearly significant) in sucrose consumption. This indicates
that chronic pain may lead to depressive-like behaviors.
UCMS model is one of the classical depression models. In
the current study, chronic stress resulted in a significant de-
crease of sucrose preference in rats, demonstrating that
the animal model has been successfully established. The
open field test showed that the stressed rats displayed
higher locomotor activities, reflecting the psychomotor
agitation observed in some depressed humans.17,28 The ex-
ploratory behaviors of the stressed rats exhibited lower ac-
tivity, suggesting a change in the emotionality.39 Anxiety
behaviors were evaluated by the time spent in the open
arms in EPM. It has been reported that anxiety and depres-
sion are often comorbid with each other.11,19,35 However,
the increased EPM open-arm time during UCMS exposure
in this study indicates an anxiolytic effect of chronic mild
stress but not an anxiogenic effect. It is difficult to under-
stand the conflicting observations of decreased and
increased anxiety-like behavior in the EPM test after
UCMS.9,16,26,36 Very recently, Kompagne et al20 reported
a consistent result and interpreted the increased EPM
open-arm time as reflecting the dampened emotional pro-
cessing of the sensory input but not a lessanxious state. Wealso examined the HPA activity and found that the adrenal
weight was increased, indicating the hyperactivity of HPA
in the depressive state.3 Meanwhile, the plasma level of
corticosterone remainedunchangedafterUCMSexposure.
It has been proposed that there is an adaptive response of
HPA axis in the presence of prolonged high glucocorticoid
concentrations.4,18,31 Previous studies measuring the corti-
costerone level weekly after UCMS also demonstrated that
the corticosterone level increased at the beginning,
decreased at the second week, and returned to baseline
level at the end of the sixth week of UCMS.39
A limitation of the experimental design should be ad-
dressed here. The completion of this experiment needs
a long period of time (4 to 5 months). Study 1 and 2
were carried out in spring (March/April) and summer
(June/July), respectively. Although the thermal stimuli
used in both studies were of the same intensity, the
pain thresholds (ie, PWLs) varied between the control
groups in Study 1 and 2 (6.37 60.11 vs. 10.1 6 .27
seconds). The seasonal effect was thought to be a reason
affecting pain thresholds. Pöllmann and Harris34 have
reported significant circannual rhythm of pain sensitivity
in human subjects.34 They elicited pain with a cold stimu-
lus and found that the pain thresholds were significantly
higher in cold season (winter) than in warm season
(spring). Thus, it is reasonable that the pain thresholds
to heat stimuli are higher in summer and lower in win-
ter/spring, as the present study has shown. The same rea-
soning is also applicable for the formalin data, for the
formalin test is a model of inflammatory pain, which
can be affected by seasonal temperature changes.
228 Depression Regulates Evoked and Spontaneous PainIn conclusion, our studies demonstrated that: 1) de-
pression inhibited evoked but facilitated spontaneous
pain behaviors in rats; and 2) persistent pain may cause
depressive behaviors. These findings suggest that the un-
derlying mechanisms of the modulation of the evoked
and spontaneous pain perception in the depressive state
are different, and that there is a strong interactive rela-
tionship between pain and depression. Future studies
may be designed to identify the different roles of 5-HT
in mediating chronic pain and depression, and the sepa-rate areas, specific transmitters, or signaling molecules
associated with evoked and spontaneous pain in de-
pressed state, thus to help build better strategies for
the treatment of depression and chronic pain.Acknowledgments
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